What is the lymphom nk T-cell?

Lymphoma

nk T-cells is an aggressive type of cancer that attacks natural killer cells and/or T-cells used by the immune system to combat viruses, bacteria and tumor cells. This disease is also known as the lymphoma of the nk of the nasal type, anglocentric lymphoma or extraanodal lymphoma of natural killers. Rare in the United States This form of non-hodgkins lymphoma affects primarily Asian or Latin-American decent people. Sometimes it is associated with the Epstein-Barr virus. These are categorized as a group of white blood cells known as lymphocytes that attack viruses and tumor cells, often found in the nasal or paranasal cavity. Since 2011, medical research had to determine whether the lymphoma of NK T-cells was caused by the destruction of natural killers or T-cells. T-cells, as well as NK cells, are lymphocytes that help maintain a healthy cellular function. In both cases, the cells have become malignant.

The extranodal term shows that lymphoma occurs outside the lymph nodes. Symptomsin most cases it occurs in the nasal or sinus cavity, but symptoms may occur in other extraranodal areas such as trachea, skin and gastrointestinal tract. Symptoms of Lymphoma NK T-cells may include necrosis in the nasal cavity leading to nose bleeding, mass in the nasal or sinus cavity, skin ulcers and perforation in the gastrointestinal tract. A biopsy is required to diagnose the disease. Due to the rarity of this condition, some doctors can use other technological supports such as X -rays, PET scanning, CT scanning or ultrasound to help confirm the diagnosis.

Lymphoma treatment is still being examined. The most common treatment is the chemotherapy regime named for four used medicines: cyclophosphamide, hydroxydoxorubicin, oncovin® and prednison.Režim boles are administered in four -week cycles, often repeating up to six times. Sometimes it is recommended to combine radiation and chemotherapy. Many doctors recommend aggressive treatment due to usually rapidly growing OnePower.

Lymphoma

nk T-cells was discovered and labeled as a unique lymphoma in 1994. The general nature of symptoms and the fact that some symptoms occur outside the nasal area led to various categorization and confusion of the disease at the end of the 90's. This diversity of conflict information led to a slower time line in examining the disease.